Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary
NCT00367263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2007-05-02
Summary
This study is designed to evaluate a traditional paper symptom diary system versus the VOCEL Mobile Diary. Subjects will be issued in a random order each system and asked their preference at the end of their participation.
Conditions
Interventions
- DRUG
-
Alvesco (Ciclesonide) 160 ug/day
Sponsors & Collaborators
-
Allergy & Asthma Medical Group & Research Center
lead OTHER
Principal Investigators
-
Eli O Meltzer, MD · Allergy & Asthma Medical Group & Research Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Completion
- 2006-11-30
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)
NCT00163436 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)
NCT00546520 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.
NCT00392288 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)
NCT00163397 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma
NCT00174746 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)
NCT00163358 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma
NCT00679263 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real Practice
NCT01438255 ·Status: COMPLETED
-
Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 Years) (BY9010/CA-101)
NCT00163293 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)
NCT00305461 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)
NCT00163462 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
NCT02513160 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Onset of Action 1
NCT00646620 ·Status: COMPLETED ·Phase: PHASE3
-
Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI
NCT00565591 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma
NCT00384189 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma
NCT04570657 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
NCT00073827 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
NCT06433921 ·Status: RECRUITING ·Phase: PHASE1
-
A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects
NCT00449527 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Ranging Study of A006 DPI, in Adult Asthma Patients
NCT01174732 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)
NCT00163384 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
NCT07301736 ·Status: RECRUITING ·Phase: PHASE2
-
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
NCT00867737 ·Status: UNKNOWN ·Phase: PHASE4